Alpha-adrenergic blockade in severe asthma.
Thirty-nine chronic asthmatics requiring steroids showed no response to the alpha-blocking drug indoramin during a double-blind trial.
D000293:Adolescent; D000317:Adrenergic alpha-Antagonists / Q000627:therapeutic use*; D000328:Adult; D000368:Aged; D001249:Asthma / Q000188:drug therapy*; D002908:Chronic Disease; D002986:Clinical Trials as Topic; D004311:Double-Blind Method; D006801:Humans; D007211:Indoles / Q000627:therapeutic use*; D007217:Indoramin / Q000627:therapeutic use*; D008875:Middle Aged
D000317:Adrenergic alpha-Antagonists; D007211:Indoles; D007217:Indoramin